ArticleBMC cancer2024

mFOLFIRINOX versus mFOLFOX 6 as adjuvant treatment for high-risk stage III colon cancer - the FROST trial: study protocol for a multicenter, randomized controlled, phase II trial.

Kyung-Ha Lee et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.